Toggle navigation
Home
Search
Services
Blog
Contact
About
Tumor Suppression in Glioblastoma Multiforme
Fults, Daniel Webster
University of Utah, Salt Lake City, UT, United States
Search 23 grants from Daniel Fults
Search grants from University of Utah
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
T-Cells and Diseases
Red Cell Metabolism
Cardiovascular Surgery and Bioengineering
Recently added grants:
Discovery and characterization of new bacterial cell wall targets and inhibitors to treat resistant infections
Mechanisms of Staphylococcus aureus and Pseudomonas aeruginosa Co-existence in CF
Development of a semi-quantitative ligation-based assay for Hepatitis B
Small molecule inhibitors of lytic transglycosylase to potentiate beta-lactam antibiotics
How Hepatitis C Virus Regulates Desmosterol to Affect RNA Replication: a New Virus-Host Interaction
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA052855-07
Application #
2095023
Study Section
Special Emphasis Panel (ZRG4-PTHA (01))
Project Start
1990-07-01
Project End
1998-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
7
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
University of Utah
Department
Genetics
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Related projects
NIH 1997
R01 CA
Tumor Suppression in Glioblastoma Multiforme
Fults, Daniel Webster / University of Utah
NIH 1996
R01 CA
Tumor Suppression in Glioblastoma Multiforme
Fults, Daniel Webster / University of Utah
NIH 1995
R01 CA
Tumor Suppression in Glioblastoma Multiforme
Fults, Daniel Webster / University of Utah
Publications
Rubio, Brent K; Tenney, Karen; Ang, Kean-Hooi et al.
(2009)
The marine sponge Diacarnus bismarckensis as a source of peroxiterpene inhibitors of Trypanosoma brucei, the causative agent of sleeping sickness.
J Nat Prod 72:218-22
Comments
Be the first to comment on Daniel Fults's grant